Lancet Series 2018: NCDs and Economics
2018
This Lancet Series examines the inextricable link between economic growth and controlling non-communicable diseases (NCDs) in the global efforts to achieve Sustainable Development Goal (SDG) Target 3.4—reducing premature NCD deaths by one-third by 2030. NCDs cause 70 percent of mortality worldwide, disproportionately in low- and middle-income countries. The five papers in this series highlights how poverty drives and is driven by NCDs; how price policies, like excise taxes, are feasible and cost-effective approaches to controlling NCD risk factors; and how NCD control contributes to a more productive labor force and economic growth. The Lancet Taskforce on NCDs and Economics argues that advancing the vision of SDG 3.4 is intimately connected to global progress on SDGs related to health, education, poverty, and gender equality, among others. Identifying and understanding these linkages will help build the multidisciplinary alliances and political will needed to reduce NCDs worldwide.
Series papers include:
- Investing in Non-Communicable Disease Prevention and Management to Advance the Sustainable Development Goals
- Tackling Socioeconomic Inequalities and Non-Communicable Diseases in Low-Income and Middle-Income Countries Under the Sustainable Development Agenda
- Action to Address the Household Economic Burden of Non-Communicable Diseases
- Equity Impacts of Price Policies to Promote Healthy Behaviors
- Investing in Non-Communicable Diseases: An Estimation of the Return on Investment for Prevention and Treatment Services
Lancet Series 2018: NCDs and Economics
Source:
The Lancet Taskforce on NCDs and Economics. The Lancet 2018. https://www.thelancet.com/series/Taskforce-NCDs-and-economics.